Pariglasgene brecaparvovec, sold under the brand name Genglycos, is a gene therapy medication used for the treatment of glycogen storage disease type Ia. Pariglasgene brecaparvovec is an adeno-associated virus vector-based gene therapy.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.